Open AccessFebrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case presentation
Author(s) -
Burak Bayraktar
Publication year - 2021
Publication title -
the pan african medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.287
H-Index - 30
ISSN - 1937-8688
DOI - 10.11604/pamj.2021.38.17.27507
Subject(s) - medicine , methotrexate , ectopic pregnancy , neutropenia , febrile neutropenia , regimen , pregnancy , chemotherapy , surgery , pediatrics , genetics , biology
Methotrexate (MTX) is an effective, economical and safe drug used in the treatment of ectopic pregnancy. Complications are very rare. Herein, we reported a case of febrile neutropenia following single low-dose methotrexate for the treatment of ectopic pregnancy. Febrile neutropenia developed on day 4 of single-dose methotrexate administered intramuscularly. Although methotrexate single-dose regimen is quite effective and safe in ectopic pregnancy, febrile neutropenia can occur very rarely.